Page last updated: 2024-10-26

dipyridamole and Atrioventricular Nodal Reentrant Tachycardia

dipyridamole has been researched along with Atrioventricular Nodal Reentrant Tachycardia in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
"Dipyridamole was infused, and coronary sinus blood samples were obtained after 15 minutes or coincident with termination of SVT."2.68Endogenous adenosine is an antiarrhythmic agent. ( Belardinelli, L; Conti, JB; Curtis, AB; Utterback, DB, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conti, JB1
Belardinelli, L1
Utterback, DB1
Curtis, AB1

Trials

1 trial available for dipyridamole and Atrioventricular Nodal Reentrant Tachycardia

ArticleYear
Endogenous adenosine is an antiarrhythmic agent.
    Circulation, 1995, Mar-15, Volume: 91, Issue:6

    Topics: Adenosine; Adult; Dipyridamole; Electrocardiography; Female; Humans; Male; Middle Aged; Tachycardia,

1995